EDSA Edesa Biotech: Forvard P/S multiplikatori
Edesa Biotech, Inc. (EDSA) hukumat sherikliklari orqali respirator patologiyalarga qarshi kurashish uchun immun terapiyalarini ishlab chiqadi. Savdoning yo'qligi va kechki bosqich sinovlari davomidagi monitoring xarajatlarining ortishi oldingi sotuvlarga nisbatan narx koeffitsiyentini oshirmoqda, u hozirda darajasida turibdi. Biznesning moliyaviy barqarorligi butunlay yallig'lanishga qarshi dori vositalarining klinik sinovlari natijalariga bog'liq.
Edesa Biotech, Inc. kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Edesa Biotech, Inc.|EDSA - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Edesa Biotech, Inc.|EDSA - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Edesa Biotech Corp|EDSA - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari Edesa Biotech|Tezkor likvidlik koeffitsiyenti edesabiotech.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
EDSA - Sof moliyaviy natija|Kutilayotgan foyda Edesa Biotech, Inc.|EDSA - Kapitalizatsiyaning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Edesa|EDSA - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Edesa Biotech Corp|EDSA - Foizlar, soliqlar va eskirishdan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Edesa Biotech|EDSA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi edesabiotech.com|EDSA - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Edesa Biotech, Inc.
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning fundamental tahlili:Edesa Biotech (EDSA)
Edesa Biotech, Inc. (EDSA) kompaniyasining o'ziga xos tabiati va uning cheklangan miqdordagi respirator terapiya dori vositalariga e'tibor qaratgani biznesni klinik sinovlar natijalariga nisbatan o'ta sezgir qiladi. Forward P/S koeffitsiyentining tahlili joriy bozor kapitalizatsiyasini kutilayotgan daromadlar bilan solishtirish imkonini beradi, bu esa asossiz haddan tashqari yuqori baholanganlikni yoki o'sish potentsialini aniqlaydi, nimaiki kompaniyaning binar rivojlanish xatarlariga yuqori bog'liqligini hisobga olganda bu juda muhimdir.
Muhim raqobatchilar
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati ADMA Corp|PTGX: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati IMVT|KNSA (Kiniksa) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grifols SA GRFS|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Celldex Corp|Forvard P/S multiplikatori AUPH (Aurinia Pharmaceuticals)|Forvard P/S multiplikatori biocryst.com BCRX|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics Inc)|PHVS: Forvard P/S multiplikatori|ABCL (AbCellera Corp) - Narxning prognoz qilingan daromadga nisbati|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|precigen.com (PGEN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Pharming Group (PHAR)|NKTR - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Upstream Bio Corp - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati ZBIO (Zenas Corp)|Immunome, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati gossamerbio.com|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|SVRA: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori RIGL (Rigel Pharmaceuticals)|ANAB (anaptysbio.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ATXS (Astria Therapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc (ENGN)|RAPT - Narxning prognoz qilingan daromadga nisbati|JBIO (Aerovate Therapeutics Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ACRS: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori kyvernatx.com|Forvard narx/daromad multiplikatori TLSA|Cabaletta Bio Inc. (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori VTYX|THTX - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|ELDN: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AGEN - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Climb Bio Inc. CLYM|ZURA: Forvard P/S multiplikatori|aTyr Pharmaceuticals (ATYR) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Ikena Oncology, Inc. - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori STTK|EQ (equilliumbio.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Forvard P/S multiplikatori Immunic Therapeutics IMUX|ATRA - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx IFRX (InflaRx N.V.)|X4 Pharmaceuticals, Inc. (XFOR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Adicet Bio, Inc.|CELU (Celularity Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori INmune Bio Corporation|Forvard narx/daromad multiplikatori BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SABS (SAB Biotherapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Akari Therapeutics PLC (AKTX)|ENLV - Narxning prognoz qilingan daromadga nisbati|Q32 Bio Inc. (QTTB) - Forvard narx/daromad multiplikatori|GeoVax Labs, Inc. (GOVX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori ibioinc.com|Forvard narx/daromad multiplikatori CARM|Forvard P/S multiplikatori XTL Biopharmaceuticals Ltd|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. (AIM) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Aditxt Corp - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati GRI Bio Inc|XRTX: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HIND|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati indaptusrx.com INDP|Narxning prognoz qilingan daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati calcimedica.com|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Forvard P/S multiplikatori Allakos Inc ALLK|HOOK: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx IGMS (IGM Biosciences, Inc.)|ITOS: Forvard P/S multiplikatori|OCEA (Ocean Biomedical Inc) - Narxning prognoz qilingan daromadga nisbati|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Third Harmonic Bio Inc (THRD) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati
